Utrecht Coronary Biobank
Initiatives
-
UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.
At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed.
- Start Year
- 2011
- End Year
- 2014
- Funding
- UMC Utrecht
Visit UCORBIO
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Patients' cohort
- Follow Up
- At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 2,589
- Number of participants with biosamples
- Supplementary Information
- Patients undergoing coronary angiography with or without coronary intervention in the University Medical Center in Utrecht, the Netherlands.
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |